Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 03 Jun 2025 | 3,823,996 | 26,441,905 | - | 0 | Class A Ordinary Shares | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 03 Jun 2025 | 3,823,996 | 84,283,430 | - | - | Common Units in ProKidney LP | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | 03 Jun 2025 | 3,823,996 | 84,283,430 | - | - | Class B Ordinary Shares | ||
| ProKidney Corp Ordinary | Pablo Legorreta | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jun 2025 | 3,823,996 | 22,617,909 | - | 0 | Class A Ordinary Shares | |
| Oncology Institute Inc | Brad Hively | Director | Sale of securities on an exchange or to another person at price $ 2.87 per share. | 03 Jun 2025 | 1,867,605 | 712,033 | - | 2.9 | 5,360,587 | Common Stock |
| Oncology Institute Inc | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 946,460 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. | 03 Jun 2025 | 946,460 | 2,579,638 | - | 0.9 | 804,491 | Common Stock |
| Canopy Growth Corp | Luc Mongeau | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 912,733 | 912,733 | - | - | Stock Option | |
| Canopy Growth Corp | Luc Mongeau | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 727,212 | 784,899 (0%) | 0% | 0 | Common Shares | |
| Oncology Institute Inc | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. | 03 Jun 2025 | 684,528 | 1,396,561 | - | 0.9 | 581,849 | Common Stock |
| Oncology Institute Inc | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 684,528 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Payoneer Global Inc | Scott Galit | Director | Sale of securities on an exchange or to another person at price $ 6.68 per share. | 03 Jun 2025 | 612,731 | 1,092,784 | - | 6.7 | 4,096,045 | Common Stock |
| Canopy Growth Corp | Judy Hong | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 532,771 | 532,771 | - | - | Stock Option | |
| Payoneer Global Inc | Scott Galit | Director | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 03 Jun 2025 | 479,720 | 1,092,784 | - | 6.7 | 3,232,114 | Common Stock |
| Canopy Growth Corp | Judy Hong | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 424,481 | 611,518 (0%) | 0% | 0 | Common Shares | |
| Flex Ltd | Revathi Advaithi | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 384,050 | 1,644,723 (0%) | 0% | 0 | Ordinary Shares | |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 373,388 | 454,342 | - | - | Stock Options (Right to buy) | |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 03 Jun 2025 | 373,388 | 1,572,504 | - | 2.9 | 1,082,825 | Common Stock |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 03 Jun 2025 | 359,102 | 1,451,886 | - | 2.8 | 1,005,486 | Common Stock |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 359,102 | 306,288 | - | - | Stock Options (Right to buy) | |
| Complete Solaria Inc (Class A) | Thurman John Rodgers | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 03 Jun 2025 | 303,000 | 463,589 | - | 1.7 | 509,040 | Common Stock |
| Complete Solaria Inc (Class A) | Thurman John Rodgers | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 03 Jun 2025 | 303,000 | 463,588 | - | 1.7 | 509,040 | Common Stock |
| Amphenol (Class A) | Luc Walter | President, HES Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 286,000 | 0 | - | - | Stock Option | |
| Amphenol (Class A) | Luc Walter | President, HES Division | Sale of securities on an exchange or to another person at price $ 91.43 per share. | 03 Jun 2025 | 286,000 | 451,790 (0%) | 0% | 91.4 | 26,148,522 | Class A Common Stock |
| Amphenol (Class A) | Luc Walter | President, HES Division | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.55 per share. | 03 Jun 2025 | 286,000 | 737,790 (0%) | 0% | 22.6 | 6,450,015 | Class A Common Stock |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 03 Jun 2025 | 259,797 | 18,577,567 (26%) | 0% | 26.2 | 6,816,528 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 03 Jun 2025 | 259,797 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 03 Jun 2025 | 259,797 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | 03 Jun 2025 | 259,797 | 18,317,770 (26%) | 0% | 26.2 | 6,816,528 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 03 Jun 2025 | 259,797 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 03 Jun 2025 | 259,797 | 18,577,567 (26%) | 0% | 26.2 | 6,816,528 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 03 Jun 2025 | 259,797 | 18,317,770 (26%) | 0% | 26.2 | 6,816,528 | Common Stock | |
| Celsius Holdings Inc | Dean Desantis | Ten Percent Owner | 03 Jun 2025 | 259,797 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Conduit Pharma Inc | Andrew James Regan | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 3.23 per share. | 03 Jun 2025 | 154,799 | 154,799 | - | 3.2 | 500,001 | Common Stock |
| Ceco Environmental Corp | Todd R. Gleason | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 150,000 | 150,000 | - | - | Restricted Stock Units | |
| Immunic Inc | Richard Alan Rudick | Director | Purchase of securities on an exchange or from another person at price $ 0.70 per share. | 03 Jun 2025 | 143,075 | 230,375 (2%) | 1% | 0.7 | 100,024 | Common Stock |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 138,180 | 115,620 | - | - | Stock Options (Right to buy) | |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.74 per share. | 03 Jun 2025 | 138,180 | 1,705,515 | - | 2.7 | 378,613 | Common Stock |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 137,700 | 0 | - | - | Restricted Stock Units | |
| Ford Motor | Sherry House | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 132,436 | 0 | - | - | Ford Stock Units | |
| Ford Motor | Sherry House | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 132,436 | 235,313 (0%) | 0% | - | Common Stock, $0.01 par value | |
| Vivid Seats Inc (Class A) | Adam Stewart | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 131,578 | 131,578 | - | - | Restricted Stock Units | |
| Oncology Institute Inc | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 131,297 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share. | 03 Jun 2025 | 131,297 | 1,633,178 | - | 1.9 | 245,525 | Common Stock |
| GoPro Inc (Class A) | Susan M. Lyne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 127,358 | 338,919 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Miguel A. Lopez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 127,358 | 167,999 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Michael C. Dennison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 127,358 | 127,358 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Tyrone Ahmad-Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 127,358 | 253,464 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Shaz Kahng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 127,358 | 314,274 (0%) | 0% | 0 | Class A Common Stock | |
| GoPro Inc (Class A) | Emily S. Culp | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 127,358 | 127,358 (0%) | 0% | 0 | Class A Common Stock | |
| Nerdwallet Inc (Class A) | Samuel Yount | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 125,581 | 125,581 | - | - | Employee Stock Options (right to buy) | |
| Digimarc Corp | Carle Quinn | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 13.73 per share. | 03 Jun 2025 | 120,244 | 139,905 (1%) | 0% | 13.7 | 1,650,950 | Common Stock |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 115,449 | 827,730 | - | - | Stock Options (Right to buy) | |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.90 per share. | 03 Jun 2025 | 115,449 | 1,567,335 | - | 2.9 | 334,802 | Common Stock |
| Fold Holdings Inc (Class A) | Jonathan Kirkwood | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 112,500 | 112,500 | - | 0 | Common Stock | |
| Canopy Growth Corp | David Lazzarato | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 111,879 | 134,765 (0%) | 0% | 0 | Common Shares | |
| Oncology Institute Inc | Brad Hively | Director | Sale of securities on an exchange or to another person at price $ 2.87 per share. | 03 Jun 2025 | 108,532 | 603,501 | - | 2.9 | 311,519 | Common Stock |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 106,332 | 88,962 | - | - | Stock Options (Right to buy) | |
| Payoneer Global Inc | Scott Galit | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.02 per share. | 03 Jun 2025 | 106,332 | 1,199,116 | - | 3.0 | 321,123 | Common Stock |
| Oncology Institute Inc | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 105,320 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Oncology Institute Inc | Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.48 per share. | 03 Jun 2025 | 105,320 | 1,501,881 | - | 0.5 | 50,659 | Common Stock |
| Robinhood Markets Inc (Class A) | Steven M. Quirk | Chief Brokerage Officer | Sale of securities on an exchange or to another person at price $ 70.14 per share. | 03 Jun 2025 | 104,887 | 228,621 | - | 70.1 | 7,356,942 | Class A Common Stock |
| Lexicon Pharma Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,806 | 103,806 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Samuel L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,806 | 103,806 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,806 | 103,806 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Philippe J. Amouyal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,806 | 103,806 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Judith L. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,806 | 103,806 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Diane E. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,806 | 103,806 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharma Inc | Ivan H. Cheung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,806 | 103,806 | - | - | Stock Option (Right to Buy) | |
| W & T Offshore Inc | John D. Buchanan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,448 | 103,448 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Nancy T. Chang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,448 | 103,448 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Virginia Boulet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,448 | 103,448 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | B. Frank Stanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,448 | 103,448 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,448 | 103,448 | - | - | Restricted Stock Units | |
| Elicio Therapeutics Inc | Yekaterina Chudnovsky | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 103,225 | 103,225 | - | - | Warrant (right to buy) | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.01 per share. | 03 Jun 2025 | 102,485 | 756,304 | - | 46.0 | 4,715,724 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.01 per share. | 03 Jun 2025 | 102,187 | 65,558 | - | 46.0 | 4,701,951 | Class A Common Stock |
| Cadre Holdings Inc | Warren B. Kanders | Director, CEO AND CHAIRMAN, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.51 per share. | 03 Jun 2025 | 100,000 | 10,366,192 | - | 33.5 | 3,351,000 | Common Stock, par value $0.0001 per share ("Common Stock") |
| B. Riley Fin Inc | Scott Yessner | Executive VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock | |
| Dave Inc (Class A) | Jason Wilk | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 100,000 | 398,078 | - | 0 | Class A Common Stock | |
| Dave Inc (Class A) | Jason Wilk | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 100,000 | 1,414,082 | - | - | Class V Common Stock | |
| Lexicon Pharma Inc | Raymond Debbane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 89,312 | 89,312 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Samuel L. Barker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 89,312 | 89,312 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Christopher J. Sobecki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 89,312 | 89,312 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Philippe J. Amouyal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 89,312 | 89,312 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Judith L. Swain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 89,312 | 89,312 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Diane E. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 89,312 | 89,312 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Ivan H. Cheung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 89,312 | 89,312 | - | - | Restricted Stock Units | |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 86,064 | 0 | - | - | Restricted Stock Units | |
| Adc Therapeutics SA | Timothy P. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 80,000 | 80,000 | - | - | Stock Options (Right to Buy) | |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 76,676 | 76,776 | - | - | Restricted Stock Units | |
| Capital One | Richard D. Fairbank | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 76,675 | 4,101,221 (0%) | 0% | 0 | Common Stock | |
| Surf Air Mobility Inc | Sudhin Shahani | Director | Sale of securities on an exchange or to another person at price $ 2.43 per share. | 03 Jun 2025 | 75,840 | 549,578 | - | 2.4 | 184,291 | Common Stock |
| Canopy Growth Corp | Theresa Yanofsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 74,586 | 94,785 (0%) | 0% | 0 | Common Shares | |
| Canopy Growth Corp | Willy J. Kruh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 74,586 | 83,858 (0%) | 0% | 0 | Common Shares | |
| W & T Offshore Inc | John D. Buchanan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 73,892 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | John D. Buchanan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Nancy T. Chang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Nancy T. Chang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 112,652 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | Virginia Boulet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Virginia Boulet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 444,149 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | B. Frank Stanley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | B. Frank Stanley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 393,625 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 73,892 | 147,628 (0%) | 0% | - | Common Stock | |
| Dell | Richard J. Rothberg | General Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 108.82 per share. | 03 Jun 2025 | 70,165 | 79,928 (0%) | 0% | 108.8 | 7,635,355 | Class C Common Stock |
| Eton Pharma Inc | Sean E. Brynjelsen | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 16.81 per share. | 03 Jun 2025 | 70,000 | 2,873,513 (16%) | 0% | 16.8 | 1,176,700 | Common Stock |
| Eton Pharma Inc | Sean E. Brynjelsen | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 03 Jun 2025 | 70,000 | 2,943,513 (16%) | 0% | 17 | 1,190,000 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 69,169 | 152,169 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 69,169 | 1,075,589 (3%) | 0% | - | Common Stock | |
| Flex Ltd | Scott Offer | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 69,130 | 175,407 (0%) | 0% | 0 | Ordinary Shares | |
| Flex Ltd | Michael P. Hartung | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 69,130 | 328,588 (0%) | 0% | 0 | Ordinary Shares | |
| NET Power Inc (Class A) | Ralph Alexander | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 67,568 | 104,381 | - | 0 | Restricted Stock Units | |
| NET Power Inc (Class A) | Joseph T. Kelliher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 67,568 | 104,381 | - | 0 | Restricted Stock Units | |
| NET Power Inc (Class A) | A. Alejandra Veltmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 67,568 | 104,381 | - | 0 | Restricted Stock Units | |
| NET Power Inc (Class A) | Carol Peterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 67,568 | 104,381 | - | 0 | Restricted Stock Units | |
| Zscaler Inc | Raj Judge | Director, EVP, Corp. Strategy & Ventures | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 67,148 | 69,298 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharma Inc | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,431 | 0 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharma Inc | David W.J. McGirr | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 03 Jun 2025 | 65,431 | 68,431 (0%) | 0% | 4.6 | 300,328 | Common Stock |
| Rimini Street Inc | Steven M. Capelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 65,335 | 272,994 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Steven M. Capelli | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,335 | 0 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Jack L. Acosta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,335 | 0 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Jack L. Acosta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,335 | 273,994 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Robin P. Murray | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,335 | 272,994 (0%) | 0% | 0 | Common Stock | |
| Rimini Street Inc | Robin P. Murray | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,335 | 0 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Jay Snyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,335 | 0 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Jay Snyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 65,335 | 226,018 (0%) | 0% | 0 | Common Stock | |
| Seagate Tech | Ban Seng Teh | EVP & Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 03 Jun 2025 | 63,418 | 14,658 (0%) | 0% | 125.0 | 7,927,294 | Ordinary Shares |
| Steris PLC | Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 63,328 | 63,328 | - | - | Employee Stock Option (right to buy) | |
| Nerdwallet Inc (Class A) | Samuel Yount | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 62,790 | 647,241 | - | 0 | Class A Common Stock | |
| Bristol-Myers Squibb | Christopher S. Boerner | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2025 | 62,720 | 62,719 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb | Christopher S. Boerner | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2025 | 62,720 | 62,720 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | 03 Jun 2025 | 62,500 | 46,552,895 | - | - | Class A Units | ||
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | 03 Jun 2025 | 62,500 | 46,615,395 | - | - | Class A Units | ||
| Eton Pharma Inc | Sean E. Brynjelsen | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.38 per share. | 03 Jun 2025 | 60,945 | 3,022,568 (16%) | 0% | 17.4 | 1,059,224 | Common Stock |
| Cerus Corp | Daniel N. Swisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 207,045 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Witney Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 280,059 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Eric H. Bjerkholt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 222,133 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Jami Dover Nachtsheim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 208,362 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Timothy L. Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 205,073 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Ann Lucena | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 172,284 (0%) | 0% | 0 | Common Stock | |
| Cerus Corp | Hua Shan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 60,000 | 132,386 (0%) | 0% | 0 | Common Stock | |
| Core Scientific Inc - Ordinary Shares - New | Todd M. Duchene | See remarks | Sale of securities on an exchange or to another person at price $ 11.33 per share. | 03 Jun 2025 | 60,000 | 2,100,102 | - | 11.3 | 679,884 | Common Stock |
| Flex Ltd | Revathi Advaithi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 42.90 per share. | 03 Jun 2025 | 59,150 | 1,260,673 (0%) | 0% | 42.9 | 2,537,624 | Ordinary Shares |
| Global Business Travel Grp Inc (Class A) | Eric John Bock | See remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2025 | 58,500 | 2,114,354 | - | 0 | Class A Common Stock | |
| Ford Motor | Sherry House | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.98 per share. | 03 Jun 2025 | 57,743 | 177,570 (0%) | 0% | 10.0 | 576,275 | Common Stock, $0.01 par value |
| GoodRx Holdings Inc (Class A) | Agnes Rey-Giraud | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 57,050 | 160,667 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Ian T. Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 57,050 | 82,902 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Scott W. Wagner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 57,050 | 182,204 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Kelly J. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 57,050 | 111,062 | - | 0 | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Douglas Hirsch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 57,050 | 211,388 | - | 0 | Class A Common Stock | |
| Rimini Street Inc | Steven M. Capelli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 55,727 | 55,727 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Jack L. Acosta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 55,727 | 55,727 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Robin P. Murray | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 55,727 | 55,727 | - | - | Restricted Stock Units | |
| Rimini Street Inc | Jay Snyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 55,727 | 55,727 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | David W.J. McGirr | Director | Sale of securities on an exchange or to another person at price $ 65.15 per share. | 03 Jun 2025 | 55,558 | 12,873 (0%) | 0% | 65.1 | 3,619,404 | Common Stock |
| Dave Inc (Class A) | Jason Wilk | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 208.54 per share. | 03 Jun 2025 | 55,368 | 332,114 | - | 208.5 | 11,546,443 | Class A Common Stock |
| Richtech Robotics Inc (Class B) | Phil Zheng | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.53 per share. | 03 Jun 2025 | 54,787 | 1,200,000 | - | 2.5 | 138,611 | Class B Common Stock |
| Nano Nuclear Energy Inc | Jaisun Garcha | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 51,645 | 0 | - | - | Restricted Stock Units | |
| Zscaler Inc | Kevin Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 51,383 | 51,383 (0%) | 0% | 0 | Common Stock | |
| Cogent Comm Holdings Inc | David Schaeffer | Director, CHAIRMAN, CEO, AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 47.00 per share. | 03 Jun 2025 | 50,000 | 3,946,721 (8%) | 0% | 47.0 | 2,349,985 | common stock |
| ATI Inc | Robert S. Wetherbee | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 81.64 per share. | 03 Jun 2025 | 50,000 | 406,538 (0%) | 0% | 81.6 | 4,082,000 | Common Stock, par value $0.10 per share |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | 03 Jun 2025 | 50,000 | 50,000 (0%) | 0% | - | Class A Common Stock | ||
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jun 2025 | 50,000 | 37,242,317 (73%) | 0% | - | Class B Common Stock | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 03 Jun 2025 | 50,000 | 37,292,317 (73%) | 0% | - | Class B Common Stock | |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | 03 Jun 2025 | 50,000 | 50,000 (0%) | 0% | - | Class A Common Stock | ||
| Navitas Semiconductor Corp | Richard J. Hendrix | Director | Sale of securities on an exchange or to another person at price $ 6.33 per share. | 03 Jun 2025 | 50,000 | 104,792 | - | 6.3 | 316,500 | Class A Common Stock |
| Zscaler Inc | Kevin Rubin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Core & Main Inc (Class A) | Laura K. Schneider | Chief Human Resources Officer | 03 Jun 2025 | 45,695 | 0 | - | - | Class B Common Stock and Limited Partnership Interests | ||
| Core & Main Inc (Class A) | Laura K. Schneider | Chief Human Resources Officer | Other type of transaction at price $ 0.00 per share. | 03 Jun 2025 | 45,695 | 45,695 | - | - | Class B Common Stock and Limited Partnership Interests | |
| Core & Main Inc (Class A) | Laura K. Schneider | Chief Human Resources Officer | Other type of transaction at price $ 0.00 per share. | 03 Jun 2025 | 45,695 | 473,233 | - | - | Class B Common Stock and Limited Partnership Interests | |
| Core & Main Inc (Class A) | Laura K. Schneider | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 56.25 per share. | 03 Jun 2025 | 45,695 | 12,873 | - | 56.2 | 2,570,293 | Class A Common Stock |
| Core & Main Inc (Class A) | Laura K. Schneider | Chief Human Resources Officer | 03 Jun 2025 | 45,695 | 58,568 | - | 0 | Class A Common Stock | ||
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.61 per share. | 03 Jun 2025 | 45,000 | 6,363,376 | - | 12.6 | 567,671 | Class A Common Stock |
| Immunic Inc | Glenn Whaley | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 03 Jun 2025 | 45,000 | 95,510 (0%) | 0% | 0.7 | 32,076 | Common Stock |
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 44,640 | 3,530,902 | - | - | Class B Common Stock | |
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 44,640 | 566,256 | - | - | Restricted Stock Units | |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 44,640 | 5,441,554 | - | - | Class B Common Stock | |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 44,640 | 566,256 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 43,620 | 0 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.59 per share. | 03 Jun 2025 | 43,620 | 245,445 (0%) | 0% | 4.6 | 200,216 | Common Stock |
| Rhythm Pharma Inc | David P. Meeker | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 65.04 per share. | 03 Jun 2025 | 43,346 | 202,099 (0%) | 0% | 65.0 | 2,819,358 | Common Stock |
| AlTi Global Inc (Class A) | Michael Tiedemann | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 03 Jun 2025 | 42,198 | 541,143 | - | 3.5 | 146,430 | Class A Common Stock |
| Richtech Robotics Inc (Class B) | Phil Zheng | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.48 per share. | 03 Jun 2025 | 40,000 | 1,254,787 | - | 2.5 | 99,200 | Class B Common Stock |
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | 03 Jun 2025 | 40,000 | 1,841,190 | - | - | Class B Common Stock | ||
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | 03 Jun 2025 | 40,000 | 47,417 (0%) | 0% | 0 | Class A Common Stock | ||
| Adc Therapeutics SA | Ron Squarer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 40,000 | 108,811 | - | 0 | Common Shares | |
| Adc Therapeutics SA | Victor Sandor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 40,000 | 120,886 | - | 0 | Common Shares | |
| Adc Therapeutics SA | Jean-Pierre Bizzari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 40,000 | 119,502 | - | 0 | Common Shares | |
| Adc Therapeutics SA | Robert W. Azelby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 40,000 | 93,005 | - | 0 | Common Shares | |
| Adc Therapeutics SA | Viviane Monges | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 40,000 | 146,627 | - | 0 | Common Shares | |
| Adc Therapeutics SA | Peter Hug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 40,000 | 222,644 | - | 0 | Common Shares | |
| 374Water Inc | Stephen J. Jones | Director | Purchase of securities on an exchange or from another person at price $ 0.48 per share. | 03 Jun 2025 | 40,000 | 179,593 | - | 0.5 | 19,000 | Common Stock |
| Adc Therapeutics SA | Timothy P. Coughlin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 40,000 | 40,000 | - | 0 | Common Shares | |
| Fox Corp (Class A) | Steven Tomsic | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.26 per share. | 03 Jun 2025 | 39,642 | 173,565 (0%) | 0% | 40.3 | 1,595,987 | Class A Common Stock |
| Fox Corp (Class A) | Steven Tomsic | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 03 Jun 2025 | 39,642 | 133,923 (0%) | 0% | 55.3 | 2,192,203 | Class A Common Stock |
| Fox Corp (Class A) | Steven Tomsic | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 39,642 | 75,698 | - | - | Stock Option (Right to Buy) | |
| Comtech Telecom Corp | Jeffery Paul Robertson | President, T&W Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 38,911 | 104,648 | - | - | Restricted Stock Units | |
| Comtech Telecom Corp | Jeffery Paul Robertson | President, T&W Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 38,911 | 62,422 (0%) | 0% | - | Common Stock Par Value $0.10 Per Share | |
| Sherwin-Williams | Allen J. Mistysyn | SVP - Finance & CFO | 03 Jun 2025 | 38,500 | 13,050 (0%) | 0% | 0 | Common Stock | ||
| Sherwin-Williams | Allen J. Mistysyn | SVP - Finance & CFO | 03 Jun 2025 | 38,500 | 38,500 (0%) | 0% | 0 | Common Stock | ||
| Gannett Co Inc | John Jeffry Louis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 35,816 | 619,832 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Kevin M. Sheehan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 35,816 | 223,346 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Theodore P. Janulis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 35,816 | 268,346 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Laurence Tarica | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 35,816 | 1,125,479 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Barbara W. Wall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 35,816 | 427,939 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Debra A. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 35,816 | 260,041 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Amy E. Reinhard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 35,816 | 159,541 (0%) | 0% | 0 | Common Stock | |
| Gannett Co Inc | Maha Al-Emam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 35,816 | 66,680 (0%) | 0% | 0 | Common Stock | |
| Flex Ltd | Scott Offer | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 42.87 per share. | 03 Jun 2025 | 35,394 | 140,013 (0%) | 0% | 42.9 | 1,517,288 | Ordinary Shares |
| Flex Ltd | Michael P. Hartung | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 42.87 per share. | 03 Jun 2025 | 35,393 | 293,195 (0%) | 0% | 42.9 | 1,517,280 | Ordinary Shares |
| Heico Corp (Class A) | Alan Schriesheim | Director | Sale of securities on an exchange or to another person at price $ 298.36 per share. | 03 Jun 2025 | 35,000 | 122,197 (0%) | 0% | 298.4 | 10,442,614 | Common Stock |
| Arteris Inc | Wayne C. Cantwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 34,732 | 262,930 | - | 0 | Common Stock | |
| Intuit | Marianna Tessel | EVP, GBSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 281.60 per share. | 03 Jun 2025 | 34,329 | 75,096 (0%) | 0% | 281.6 | 9,667,046 | Common Stock |
| Intuit | Marianna Tessel | EVP, GBSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 34,329 | 0 | - | - | Non-Qualified Stock Options (right to buy) | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.46 per share. | 03 Jun 2025 | 33,713 | 30,745 | - | 46.5 | 1,566,380 | Class A Common Stock |
| Under Armour Inc (Class A) | David E. Bergman | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jun 2025 | 33,181 | 536,526 (0%) | 0% | 0 | Class C Common Stock | |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 32,500 | 283,286 | - | - | Stock Options (Right to Buy) | |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 340.00 per share. | 03 Jun 2025 | 32,500 | 199,756 (0%) | 0% | 340 | 11,050,000 | Class A Common Stock |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.07 per share. | 03 Jun 2025 | 32,500 | 232,256 (0%) | 0% | 10.1 | 327,275 | Class A Common Stock |
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | 03 Jun 2025 | 32,484 | 10,363,422 | - | - | Class B Common Stock | ||
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | 03 Jun 2025 | 32,484 | 32,484 | - | 0 | Class A Common Stock | ||
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | 03 Jun 2025 | 32,477 | 32,477 | - | 0 | Class A Common Stock | ||
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | 03 Jun 2025 | 32,477 | 10,330,945 | - | - | Class B Common Stock | ||
| Bioventus Inc (Class A) | Philip G. Cowdy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 32,282 | 32,282 | - | - | Restricted Stock Units | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 32,235 | 213,524 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Tile Shop Hldgs Inc | Peter H. Kamin | Director | Grant, award, or other acquisition of securities at price $ 5.93 per share. | 03 Jun 2025 | 32,063 | 3,508,447 (6%) | 0% | 5.9 | 190,005 | Common Stock |
| SEACOR Marine Holdings Inc | Andrew R. Morse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 31,824 | 172,964 (0%) | 0% | 0 | Common Stock | |
| Pagaya Tech Ltd (Class A) | Sanjiv Das | President | Sale of securities on an exchange or to another person at price $ 17.15 per share. | 03 Jun 2025 | 31,382 | 74,435 | - | 17.1 | 538,201 | Class A Ordinary Share |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.97 per share. | 03 Jun 2025 | 30,610 | 1,044,979 (3%) | 0% | 17.0 | 519,452 | Common Stock |
| Warby Parker Inc (Class A) | Steven Miller | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 30,175 | 237,092 | - | 0 | Class A Common Stock | |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 03 Jun 2025 | 30,000 | 690,482 | - | 2.1 | 62,400 | Common Stock |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 30,000 | 465,559 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Nello Mainolfi | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.00 per share. | 03 Jun 2025 | 30,000 | 660,482 | - | 49 | 1,470,000 | Common Stock |
| Stoke Therapeutics Inc | Arthur A. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 29,747 | 29,747 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 29,747 | 29,747 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Julie Anne Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 29,747 | 29,747 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Garry E. Menzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 29,747 | 29,747 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Jennifer C. Burstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 29,747 | 29,747 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Adrian R. Krainer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 29,747 | 29,747 | - | - | Director Stock Option (Right to Buy) | |
| Coherent Corp | Shaker Sadasivam | Director | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 03 Jun 2025 | 29,292 | 38,622 (0%) | 0% | 80 | 2,343,360 | Common Stock |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 29,141 | 426,941 (1%) | 0% | - | Common Stock | |
| Liquidia Corp | Michael Kaseta | CFO and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 29,141 | 64,109 | - | - | Performance Stock Units | |
| Dell | Jane Tunnell | Chief Marketing Officer | Sale of securities on an exchange or to another person at price $ 111.95 per share. | 03 Jun 2025 | 28,877 | 78,373 (0%) | 0% | 111.9 | 3,232,780 | Class C Common Stock |
| AlTi Global Inc (Class A) | Kevin Moran | President and COO | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 03 Jun 2025 | 28,509 | 60,311 | - | 3.5 | 98,927 | Class A Common Stock |
| Under Armour Inc (Class A) | Yassine Saidi | Chief Product Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jun 2025 | 28,404 | 433,413 (0%) | 0% | 0 | Class C Common Stock | |
| Seagate Tech | Ban Seng Teh | EVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 28,120 | 0 | - | - | NQ Options | |
| Seagate Tech | Ban Seng Teh | EVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 75.94 per share. | 03 Jun 2025 | 28,120 | 46,733 (0%) | 0% | 75.9 | 2,135,433 | Ordinary Shares |
| Capital One | Matthew W. Cooper | General Counsel & Corp Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 28,115 | 102,486 (0%) | 0% | 0 | Common Stock | |
| Kiniksa Pharma Ltd (Class A) | Ross Moat | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 27,594 | 0 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | Ross Moat | CHIEF COMMERCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 29.02 per share. | 03 Jun 2025 | 27,594 | 9,415 (0%) | 0% | 29.0 | 800,778 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | Ross Moat | CHIEF COMMERCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.35 per share. | 03 Jun 2025 | 27,594 | 37,009 (0%) | 0% | 13.4 | 368,380 | Class A Ordinary Share |
| Nano Nuclear Energy Inc | Florent Heidet | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 27,555 | 0 | - | - | Restricted Stock Units | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.07 per share. | 03 Jun 2025 | 26,830 | 378,170 | - | 46.1 | 1,236,007 | Class A Common Stock |
| Roblox Corp (Class A) | Manuel Bronstein | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 90.20 per share. | 03 Jun 2025 | 26,798 | 468,486 | - | 90.2 | 2,417,180 | Class A Common Stock |
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 98.28 per share. | 03 Jun 2025 | 26,740 | 5,744 | - | 98.3 | 2,628,007 | Class A Common Stock |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.07 per share. | 03 Jun 2025 | 26,720 | 378,280 | - | 46.1 | 1,230,884 | Class A Common Stock |
| SEACOR Marine Holdings Inc | R. Christopher Regan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 26,637 | 78,662 (0%) | 0% | 0 | Common Stock | |
| Sprout Social Inc (Class A) | Justyn Howard | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 21.80 per share. | 03 Jun 2025 | 26,392 | 7,417 (0%) | 0% | 21.8 | 575,425 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 339.86 per share. | 03 Jun 2025 | 26,041 | 6,969 (0%) | 0% | 339.9 | 8,850,362 | Class A Common Stock |
| Under Armour Inc (Class A) | Shawn Curran | Chief Supply Chain Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jun 2025 | 25,856 | 426,244 (0%) | 0% | 0 | Class C Common Stock | |
| Coherent Corp | James Robert Anderson | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.78 per share. | 03 Jun 2025 | 25,836 | 123,378 (0%) | 0% | 76.8 | 1,983,688 | Common Stock |
| SEACOR Marine Holdings Inc | Lisa P. Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 25,600 | 31,678 (0%) | 0% | 0 | Common Stock | |
| Cadre Holdings Inc | Warren B. Kanders | Director, CEO AND CHAIRMAN, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 03 Jun 2025 | 25,000 | 10,341,192 | - | 34.0 | 849,750 | Common Stock |
| Fennec Pharma Inc | Khalid Islam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 25,000 | 225,000 | - | - | Stock Option | |
| Immunic Inc | Glenn Whaley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.56 per share. | 03 Jun 2025 | 25,000 | 50,510 (0%) | 0% | 0.6 | 14,000 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 03 Jun 2025 | 25,000 | 776,022 | - | 17 | 425,000 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.24 per share. | 03 Jun 2025 | 25,000 | 801,022 | - | 2.2 | 56,000 | Common Stock |
| Ceribell Inc | Xingjuan Chao | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 25,000 | 77,551 | - | - | Stock Option (Right to Buy) | |
| Franklin Electric Co. Inc | David M. Wathen | Director | Sale of securities on an exchange or to another person at price $ 85.25 per share. | 03 Jun 2025 | 25,000 | 24,000 (0%) | 0% | 85.3 | 2,131,318 | common stock |
| Robinhood Markets Inc (Class A) | Daniel M Gallagher | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 71.64 per share. | 03 Jun 2025 | 25,000 | 841,887 | - | 71.6 | 1,791,045 | Class A Common Stock |
| EverCommerce Inc | Matthew David Feiersrtein | President | Sale of securities on an exchange or to another person at price $ 10.02 per share. | 03 Jun 2025 | 24,571 | 2,304,166 | - | 10.0 | 246,128 | Common Stock |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 115.56 per share. | 03 Jun 2025 | 24,533 | 188,991 (0%) | 0% | 115.6 | 2,835,149 | Common Stock, $0.01 par value |
| Intuit | Marianna Tessel | EVP, GBSG | Sale of securities on an exchange or to another person at price $ 760.24 per share. | 03 Jun 2025 | 24,495 | 50,601 (0%) | 0% | 760.2 | 18,622,062 | Common Stock |
| Amazon | Jeffrey P. Bezos | Director, Executive Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2025 | 24,410 | 908,779,901 (8%) | 0% | 0 | Common Stock, par value $.01 per share | |
| Voyager Therapeutics Inc | James A. Geraghty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Michael J. Higgins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Glenn F. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Catherine J. Mackey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Steven E. Hyman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Grace E. Colon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Nancy Vitale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | Jude Onyia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Franklin Electric Co. Inc | David M. Wathen | Director | Sale of securities on an exchange or to another person at price $ 86.10 per share. | 03 Jun 2025 | 24,000 | 0 (0%) | 0% | 86.1 | 2,066,486 | common stock |
| Warner Bros. (Class A) | Debra L. Lee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 83,151 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Geoffrey Y. Yang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 157,871 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Kenneth W. Lowe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 1,101,041 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Joseph M. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 34,537 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Paula A. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 86,530 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Paul Alan Gould | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 844,357 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Anton J. Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 624,000 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Samuel A. Di Piazza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 190,922 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Daniel E. Sanchez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 44,054 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Fazal F. Merchant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 130,539 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Anthony J. Noto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 37,217 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Richard W. Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 85,570 (0%) | 0% | 0 | Series A Common Stock | |
| Datadog Inc (Class A) | Shardul Shah | Director | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 03 Jun 2025 | 23,748 | 396,121 (0%) | 0% | 120 | 2,849,760 | Class A Common Stock |
| Warby Parker Inc (Class A) | Neil Blumenthal | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jun 2025 | 23,637 | 3,507,265 | - | - | Class B Common Stock | |
| Warby Parker Inc (Class A) | David Gilboa | Director, Co-Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jun 2025 | 23,637 | 5,417,917 | - | - | Class B Common Stock | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 46.38 per share. | 03 Jun 2025 | 23,605 | 731,789 | - | 46.4 | 1,094,727 | Class A Common Stock |
| SEACOR Marine Holdings Inc | Julie Persily | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 23,525 | 92,476 (0%) | 0% | 0 | Common Stock | |
| Solaredge Tech Inc | Avery More | Director, Chairman of the Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 23,467 | 297,945 (0%) | 0% | 0 | Common Stock | |
| Dave Inc (Class A) | Jason Wilk | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 209.44 per share. | 03 Jun 2025 | 23,269 | 308,845 | - | 209.4 | 4,873,459 | Class A Common Stock |
| Capital One | Kaitlin Haggerty | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 23,003 | 44,403 (0%) | 0% | 0 | Common Stock | |
| Capital One | Mark Daniel Mouadeb | President, Card | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 23,003 | 48,098 (0%) | 0% | 0 | Common Stock | |
| Capital One | Kara West | Chief Enterprise Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 23,003 | 39,724 (0%) | 0% | 0 | Common Stock | |
| AlTi Global Inc (Class A) | Colleen A Graham | Chief Legal, Compl & Risk Ofcr | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 03 Jun 2025 | 22,934 | 41,960 | - | 3.5 | 79,581 | Class A Common Stock |
| Sprott Focus Trust Inc | W. Whitney George | Director, Ten Percent Owner, Senior Portfolio Manager | Sale of securities on an exchange or to another person at price $ 7.20 per share. | 03 Jun 2025 | 22,840 | 255,165 (0%) | 0% | 7.2 | 164,448 | Common Stock |
| LegalZoom.com Inc | John F. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 22,831 | 94,203 | - | 0 | Common Stock | |
| LegalZoom.com Inc | Sivan Whiteley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 22,831 | 96,380 | - | 0 | Common Stock | |
| LegalZoom.com Inc | Elizabeth Hamren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 22,831 | 90,080 | - | 0 | Common Stock | |
| LegalZoom.com Inc | Nathan Gooden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 22,831 | 70,484 | - | 0 | Common Stock | |
| European Wax Center Inc (Class A) | Darvin D. Lively | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 22,007 | 84,690 | - | 0 | Class A Common Stock | |
| European Wax Center Inc (Class A) | Laurie Ann Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 22,007 | 65,190 | - | 0 | Class A Common Stock | |
| European Wax Center Inc (Class A) | Nital Scott | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 22,007 | 36,221 | - | 0 | Class A Common Stock | |
| European Wax Center Inc (Class A) | Julia Hunter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 22,007 | 55,103 | - | 0 | Class A Common Stock | |
| AlTi Global Inc (Class A) | Brooke Connell | Pres, US Wealth Mgmt | Sale of securities on an exchange or to another person at price $ 3.47 per share. | 03 Jun 2025 | 21,462 | 216,388 | - | 3.5 | 74,474 | Class A Common Stock |
| Arteris Inc | Joachim Kunkel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,839 | 64,595 | - | 0 | Common Stock | |
| Arteris Inc | S. Atiq Raza | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,839 | 40,126 | - | 0 | Common Stock | |
| Arteris Inc | Claudia F. Munce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,839 | 100,851 | - | 0 | Common Stock | |
| Arteris Inc | Raman K. Chitkara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,839 | 157,867 | - | 0 | Common Stock | |
| Arteris Inc | Antonio J. Viana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,839 | 41,679 | - | 0 | Common Stock | |
| Dave Inc (Class A) | Jason Wilk | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 212.59 per share. | 03 Jun 2025 | 20,764 | 264,931 | - | 212.6 | 4,414,219 | Class A Common Stock |
| CarGurus Inc (Class A) | Langley Steinert | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.28 per share. | 03 Jun 2025 | 20,639 | 499,715 (0%) | 0% | 31.3 | 645,689 | Class A Common Stock |
| Under Armour Inc (Class A) | Kara Trent | President of the Americas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jun 2025 | 20,343 | 420,697 (0%) | 0% | 0 | Class C Common Stock | |
| Fennec Pharma Inc | Chris A. Rallis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,000 | 200,533 | - | - | Stock Option | |
| Fennec Pharma Inc | Marco M. Brughera | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,000 | 215,545 | - | - | Stock Option | |
| Fennec Pharma Inc | Jodi A. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,000 | 140,000 | - | - | Stock Options | |
| Mannatech Inc | Landen Granvel Fredrick | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,000 | 44,000 | - | - | Right to Purchase Common Stock | |
| Distribution Soln Grp Inc | Cesar A. Lanuza | President and CEO | Grant, award, or other acquisition of securities at price $ 27.55 per share. | 03 Jun 2025 | 20,000 | 80,498 (0%) | 0% | 27.6 | 551,000 | Common Stock |
| SEMrush Holdings Inc (Class A) | Anna Baird | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 03 Jun 2025 | 20,000 | 26,556 | - | 10 | 200,000 | Class A Common Stock |
| Mannatech Inc | Landen Granvel Fredrick | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 20,000 | 44,000 | - | - | Right to Purchase Common Stock | |
| Under Armour Inc (Class A) | Kevin A. Plank | Director, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jun 2025 | 19,947 | 4,277,789 (1%) | 0% | 0 | Class C Common Stock | |
| Comtech Telecom Corp | Jeffery Paul Robertson | President, T&W Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.10 per share. | 03 Jun 2025 | 19,760 | 42,662 (0%) | 0% | 2.1 | 41,496 | Common Stock Par Value $0.10 Per Share |
| Build A Bear Workshop Inc | Sharon Price John | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.30 per share. | 03 Jun 2025 | 19,605 | 302,950 (1%) | 0% | 45.3 | 888,124 | Common Stock |
| CVRx Inc | Joseph P. Slattery | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,554 | 19,554 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Kevin J. Ballinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,554 | 19,554 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Mitchell C. Hill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,554 | 19,554 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Mudit K. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,554 | 19,554 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Kirk Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,554 | 19,554 | - | - | Stock Option (right to buy) | |
| CVRx Inc | Martha Shadan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,554 | 19,554 | - | - | Stock Option (right to buy) | |
| Grindr Inc (Class A) | J. Michael Gearon | Director | Sale of securities on an exchange or to another person at price $ 24.75 per share. | 03 Jun 2025 | 19,432 | 5,480,568 | - | 24.8 | 480,942 | Common Stock |
| Tile Shop Hldgs Inc | Deborah K. Glasser | Director | Grant, award, or other acquisition of securities at price $ 5.93 per share. | 03 Jun 2025 | 19,407 | 183,229 (0%) | 0% | 5.9 | 115,006 | Common Stock |
| Digital Turbine Inc | Michael Akkerman | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.58 per share. | 03 Jun 2025 | 19,313 | 348,136 (0%) | 0% | 4.6 | 88,454 | Common Stock |
| e.l.f. Beauty Inc | Scott K. Milsten | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,167 | 130,696 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Kory Marchisotto | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,167 | 171,659 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Joshua Allen Franks | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,167 | 133,827 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Jennifer Catherine Hartnett | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,167 | 73,330 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| LendingClub Corp | Allan R. Landon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| LendingClub Corp | Stephen M. Cutler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| LendingClub Corp | John C. Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| LendingClub Corp | Michael P. Zeisser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| LendingClub Corp | Timothy J. Mayopoulos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| LendingClub Corp | Erin Selleck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| LendingClub Corp | Kathryn S. Reimann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| LendingClub Corp | Janey Whiteside | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 19,121 | 19,121 (0%) | 0% | 0 | Common Stock | |
| Rubrik Inc (Class A) | Arvind Nithrakashyap | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 98.55 per share. | 03 Jun 2025 | 18,955 | 13,529 | - | 98.5 | 1,868,015 | Class A Common Stock |
| Hillman Soln Corp | John Swygert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 57,497 | - | 0 | Common Stock | |
| Hillman Soln Corp | Teresa S. Gendron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 64,704 | - | 0 | Common Stock | |
| Hillman Soln Corp | Diane C. Honda | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 47,167 | - | 0 | Common Stock | |
| Hillman Soln Corp | Aaron P. Jagdfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 229,529 | - | 0 | Common Stock | |
| Hillman Soln Corp | Daniel O'Leary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 74,704 | - | 0 | Common Stock | |
| Hillman Soln Corp | David A. Owens | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 64,704 | - | 0 | Common Stock | |
| Hillman Soln Corp | Philip K. Woodlief | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 74,704 | - | 0 | Common Stock | |
| Hillman Soln Corp | Diana Dowling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,893 | 64,704 | - | 0 | Common Stock | |
| Liquidia Corp | Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 18,792 | 590,514 (2%) | 0% | - | Common Stock | |
| Liquidia Corp | Russell Schundler | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 18,792 | 41,343 | - | - | Performance Stock Units | |
| Cincinnati Financial | Donald J. Doyle | Sr Vice President - Subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.19 per share. | 03 Jun 2025 | 18,607 | 60,588 (0%) | 0% | 71.2 | 1,324,632 | Common Stock |
| Cincinnati Financial | Donald J. Doyle | Sr Vice President - Subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 18,607 | 0 | - | - | Stock Option (Right to Buy) | |
| Acushnet Holdings Corp | Sean S. Sullivan | Executive Vice President, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.24 per share. | 03 Jun 2025 | 18,486 | 93,405 (0%) | 0% | 68.2 | 1,261,527 | Common Stock |
| SEACOR Marine Holdings Inc | Alfredo Miguel Bejos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,337 | 139,883 (0%) | 0% | 0 | Common Stock | |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 18,299 | 0 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 28.80 per share. | 03 Jun 2025 | 18,299 | 27,009 (0%) | 0% | 28.8 | 527,011 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | Mark Ragosa | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 03 Jun 2025 | 18,299 | 45,308 (0%) | 0% | 18 | 329,382 | Class A Ordinary Share |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Marc Tessier-Lavigne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | David P. Schenkein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 18,111 | 18,111 | - | - | Stock Option (right to buy) | |
| Steris PLC | Daniel A. Carestio | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 17,811 | 70,932 (0%) | 0% | 0 | Ordinary Shares | |
| LoanDepot Inc (Class A) | Jeff Walsh | President, LDI Mortgage | 03 Jun 2025 | 17,763 | 4,214,708 (6%) | 0% | 0 | Class A Common Stock | ||
| LoanDepot Inc (Class A) | Jeff Walsh | President, LDI Mortgage | 03 Jun 2025 | 17,763 | 17,613 | - | - | Common Units | ||
| LoanDepot Inc (Class A) | Jeff Walsh | President, LDI Mortgage | Other type of transaction at price $ 0.00 per share. | 03 Jun 2025 | 17,763 | 17,613 | - | 0 | Class C Common Stock | |
| Liquidia Corp | Rajeev Saggar | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 17,654 | 280,806 (0%) | 0% | - | Common Stock | |
| Liquidia Corp | Rajeev Saggar | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 17,654 | 38,838 | - | - | Performance Stock Units | |
| Seagate Tech | Ban Seng Teh | EVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 17,575 | 24,605 | - | - | NQ Options | |
| Seagate Tech | Ban Seng Teh | EVP & Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.31 per share. | 03 Jun 2025 | 17,575 | 78,076 (0%) | 0% | 64.3 | 1,130,248 | Ordinary Shares |
| Phathom Pharma Inc | Frank L. Karbe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharma Inc | James N. Topper | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharma Inc | Michael F. Cola | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharma Inc | Heidi Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharma Inc | Mark Stenhouse | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Phathom Pharma Inc | Asit Parikh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Townsquare Media Inc (Class A) | Erik Hellum | COO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 03 Jun 2025 | 17,305 | 741,643 (5%) | 0% | 7 | 121,135 | Class A Common Stock |
| Carvana Co. (Class A) | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 335.86 per share. | 03 Jun 2025 | 17,145 | 4,446 (0%) | 0% | 335.9 | 5,758,378 | Class A Common Stock |
| Under Armour Inc (Class A) | Mehri Shadman-Valavi | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 03 Jun 2025 | 17,125 | 208,083 (0%) | 0% | 0 | Class C Common Stock | |
| Flywire Corp | Diane E. Offereins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 16,990 | 47,219 | - | 0 | Voting Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.